Sean Larkin, MBA is responsible for developing and executing the end-to-end strategy for the Disease Area Stronghold focused on inflammatory bowel disease. In this role, he leads all new product commercialization activities, portfolio evaluations, business development strategies and opportunity assessments. With nearly 20 years of experience in pharmaceutical marketing, sales, market analytics and new product development, Sean brings a unique perspective as he partners with regional leadership to build innovative commercialization plans that maximize the value of the industry-leading Janssen Immunology portfolio and current pipeline of new therapies.
Collaborating in more than 150 markets.
By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com.
These sections or websites are governed by their own Legal and Privacy Policies.
Europe, Middle East & Africa (EMEA)